In this proposed study, doctors aim to determine if autologous endothelial stem cell therapy may be able to reverse liver cirrhosis for patients who do not qualify for liver transplant. If proven successful, this stem cell therapy represents a major step forward in efforts to bring regenerative medicine to liver patients.
Click on the links below for the news reports:
For enquiries about the clinical trial, please contact:
Ms Nur Halisah Binte Jumat
Tel: 6601 5193 (from 9am to 5pm on weekdays)